The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...

New research shows a therapy that’s been used for cancer patients may help people with lupus go into remission.

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology ...

A new international multicenter study published in the Journal of Cellular and Molecular Medicine provides important real-world evidence on the use of CD19-targeted chimeric antigen receptor (CAR) ...

CHICAGO — De novo autoimmune diseases, including myositis, vasculitis and lupus, may occur after chimeric antigen receptor ...

To manage the finances of CAR-T therapies, which can cost up to $1 million each, health systems are increasingly using “pay for performance” deals, according to a Nov. 17 article in Specialty Pharmacy ...

Frederick L. Locke, MD, chair in the department of blood and marrow transplant and cellular immunotherapy at Moffitt Cancer ...

When your body's immune cells attack you instead of protecting you, today's treatments tamp down the friendly fire but they ...

Immune cells that have been genetically engineered to kill cancerous cells, known as CAR T-cells, have transformed the treatment of blood cancers such as leukaemia, but have proved largely ineffective ...

Community Health System and Valley Children’s Healthcare are leading the charge in Central Valley cancer treatment, bringing advanced cellular and gene therapies — including CAR-T therapy — closer to ...